To the Editor: The project IMPAC-TDC is an ongoing randomized trial performed by the Teledermatology Network of the Hospital Universitario Virgen Macarena to analyze the potential benefit gained from the addition of dermoscopic images to an internet-based skin cancer triage system between primary care centers and the skin cancer clinic. 1 This interim analysis included the first 125 patients recruited in each study group (n ¼ 250). The interventions compared in this trial were internetbased consultations based on clinical images only (clinical teleconsultations [CTC] ) and teleconsultations including both clinical and dermoscopic images (dermoscopic teleconsultation [CTC1DTC]). Patients with lesions suspicious of skin cancer and those lacking exclusion criteria for teleconsultation (multiple lesions, congenital lesions, and lesions arising on mucosal surfaces or hairy areas) were enrolled up to a final sample size of 125 patients randomized to each study group for this interim analysis 1 (Fig 1) . Both the operating general practitioner (GP) and the remote dermatologist managed and evaluated patients without knowing whether they pertained to the study (Fig 1) . Imaging was performed using a DermLite II Pro (3Gen Inc, San Juan Capistrano, CA) adapted to a Nikon J1Nikkor 10-30 mm (Nikon, Tokyo, Japan) and managed by a teledermatology internet platform. The reference test was the clinical and dermoscopic diagnosis made at the in-person visit by a dermatologist. Diagnostic performance was analyzed in terms of sensitivity, specificity, false-positive rate, and falsenegative rate for the decision regarding the referral of patients to an in-person consultation at the skin cancer unit. The diagnostic confidence level (DCL; 1, uncertain diagnosis; 2, likely diagnosis; 3, confident diagnosis), 2 the nonreferral rate, the time spent by the GP and the remote dermatologist, and the image quality were also assessed in each study group.
The most common lesion examined by teledermatology was seborrheic keratosis (29.2%, n ¼ 73), followed by common acquired melanocytic nevus (26.8%, n ¼ 67). Basal cell carcinoma was the most common malignant lesion diagnosed (6.4%, n ¼ 16), followed by squamous cell carcinoma (4%, n ¼ 10). Thus, 10.4% (n ¼ 26) of patients were referred because of malignant lesions. In the overall series, 60.8% and 76.8% of the CTC and CTC1DTC groups, respectively, were not referred to the skin cancer clinic (P ¼ .001). The subanalysis of patients having pigmented lesions increased this nonreferral percentage to 69.39% and 89.13%, respectively (P ¼ .001). The average time spent by the operating GPs was 7.44 minutes for CTC patients and 8.7 minutes for CTC1DTC patients (P ¼ .01). The time spent by the dermatologist in the evaluation of CTC or CTC1DTC patients was 1.04 minutes and 1.22 minutes, respectively (P ¼ .14). The percentage of cases with the highest DCL (DCL¼3) was 61.6% in the CTC group and 79.2% in the CTC1DTC group (P ¼ .001). The frequency of low-quality pictures was 3.2% and 1.6% in the CTC and CTC-DTC groups, respectively (P ¼ .41). The results of the diagnostic performance study are listed in Table I .
The interim results of this prospective randomized and blinded study provide meaningful favorable data ahead of the definitive results of a large-scale study on the effect of the addition of dermoscopic images to the routine internet-based skin cancer triage. 
Frequency of total body skin examinations among US dermatologists
To the Editor: Skin cancer is the most common cancer in the United States with increasing rates of both melanoma and nonmelanoma skin cancers. 1,2 The US Preventive Services Task Force states that there is insufficient evidence to assess the benefits and harms of total body skin examination (TBSE) by primary care physicians, whereas the American Academy of Dermatology and the American Cancer Society encourage routine TBSE, especially for those at high risk. 3, 4 This study aimed to clarify the frequency with which dermatologists perform TBSE.
Surveys were sent by e-mail to US dermatologists in February 2015. Respondents were asked how often 
